Invention Grant
- Patent Title: Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDS
-
Application No.: US15516296Application Date: 2015-10-23
-
Publication No.: US09907860B2Publication Date: 2018-03-06
- Inventor: Francoise Baleux , Hugues Lortat-Jacob , David Bonnaffe , Yves-Marie Coic
- Applicant: INSTITUT PASTEUR , COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES , UNIVERSITE PARIS-SUD , UNIVERSITE GRENOBLE ALPES , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Applicant Address: FR Paris FR Paris FR Orsay FR St Martin d'heres FR Paris
- Assignee: INSTITUT PASTEUR,COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES,UNIVERSITE PARIS-SUD,UNIVERSITE GRENOBLE ALPES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Current Assignee: INSTITUT PASTEUR,COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES,UNIVERSITE PARIS-SUD,UNIVERSITE GRENOBLE ALPES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Current Assignee Address: FR Paris FR Paris FR Orsay FR St Martin d'heres FR Paris
- Agency: Arrigo, Lee & Guttman LLP
- Priority: EP14306698 20141024
- International Application: PCT/EP2015/074598 WO 20151023
- International Announcement: WO2016/062854 WO 20160428
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/00 ; A61K47/64 ; C07K14/73
Abstract:
This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Said organic molecule comprises a 5 to 21 amino acid anionic polypeptide. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS.
Public/Granted literature
Information query
IPC分类:
